FDA Clears Magnetic e-Resonance Therapy for PTSD, Showing High Remission Rates
A new non-medication treatment for Post-Traumatic Stress Disorder (PTSD), Magnetic e-Resonance Therapy (MeRT), has received FDA clearance. Developed by California-based Wave Neuroscience in collaboration with researchers at the Texas A&M Health Institute of Biosciences and Technology, MeRT reported a 68 percent remission rate in clinical trials. This figure significantly surpasses the remission rates of currently approved PTSD medications, which typically reach around 10.9 percent. The treatment involves mapping a patient's brain activity using an electroencephalogram (EEG) and then employing an AI-assisted algorithm to create a personalized magnetic stimulation plan. This plan is delivered via transcranial magnetic stimulation (TMS), a technique already FDA-cleared for treatment-resistant depression. Unlike standard TMS, MeRT customizes the stimulation based on individual brain activity. Participants in the trials underwent five sessions per week for five to six weeks, with improvements observed to persis...
